Are you Dr. Simpson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
701 E El Camino Real
Mountain View, CA 94040Phone+1 650-934-7575
Summary
- Dr. Peter Simpson, MD is a gastroenterologist in Mountain View, California. He is currently licensed to practice medicine in California. He is affiliated with El Camino Health, Good Samaritan Hospital, and Mills-Peninsula Medical Center.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2003 - 2006
St Mary's Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2002
University of California, Davis, School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 150 citationsImmunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.Gil Y. Melmed, Nik Agarwal, Robert W. Frenck, Andrew Ippoliti, Patricio Ibáñez
The American Journal of Gastroenterology. 2010-01-01 - 121 citationsRacial differences in effectiveness of α‐fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosisMindie H. Nguyen, Ruel T. Garcia, Peter W. Simpson, Teresa L. Wright, Emmet B. Keeffe
Hepatology. 2002-08-01 - 45 citationsUse of endoclips in the treatment of massive colonic diverticular bleeding.Peter W. Simpson, Mindie H. Nguyen, Joseph K. Lim, Roy Soetikno
Gastrointestinal Endoscopy. 2004-03-01
Press Mentions
Complex Medicines: A Multi-Billion Pound Addition to UK IndustryJuly 19th, 2021- Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s DiseaseMarch 16th, 2021
- UK Innovators Target Nanoparticles at Inoperable CancersDecember 18th, 2020
- Join now to see all
